Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/ICY stock hub

FRA/ICY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/ICYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/ICY

In the news

Latest news · FRA/ICY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12

P25 n/aP50 n/aP75 n/a

Trailing P/E13.5

P25 n/aP50 n/aP75 n/a

ROE30.8

P25 n/aP50 n/aP75 n/a

ROIC71.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/ICY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	2,844
Employees Change	227%
Employees Change Percent	8.67
Enterprise value	EUR 13.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 16.7B
Price	EUR 83.26
Price currency	EUR
Rev Per Employee	1,634,884.9x
Sic	2836
Symbol	fra/ICY
Website	https://www.incyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.42%
EV Earnings	10.75x
EV/EBIT	10.81x
EV/EBITDA	10.1x
EV/FCF	10.61x
EV/Sales	2.93x
FCF yield	7.52%
Forward P/E	11.96x
P/B ratio	3.43x
P/E ratio	13.47x
P/S ratio	3.6x
PE Ratio10 Y	96.2x
PE Ratio3 Y	138.1x
PE Ratio5 Y	95.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.13%
EBITDA Margin	28.89%
FCF margin	27.06%
Gross margin	52.77%
Gross Profit	EUR 2.5B
Gross Profit Growth	91.9%
Gross Profit Growth Q	20.25%
Gross Profit Growth3 Y	20.72%
Gross Profit Growth5 Y	21.22%
Net Income	EUR 1.2B
Net Income Growth	6,631.44%
Net Income Growth Q	91.74%
Net Income Growth3 Y	64.04%
Net Income Growth5 Y	24.51%
Pretax Margin	33.09%
Profit Margin	26.71%
Profit Per Employee	EUR 436,632
ROA	13.89
Roa5y	7.33
ROCE	24.86
ROE	30.82
Roe5y	16.25
ROIC	71.39
Roic5y	36.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.14%
Cagr15y	13.14%
Cagr1y	59.43%
Cagr20y	17.43%
Cagr3y	11.35%
Cagr5y	4.1%
EPS Growth	7,175.4
EPS Growth Q	83.75
EPS Growth3 Y	69.59
EPS Growth5 Y	26.48
FCF Growth	379.3%
FCF Growth Q	36.61%
FCF Growth3 Y	36.07%
FCF Growth5 Y	20.6%
OCF Growth	296.45%
OCF Growth Q	38.82%
OCF Growth10 Y	23.18%
OCF Growth3 Y	32.73%
OCF Growth5 Y	14.67%
Revenue Growth	21.48x
Revenue Growth Q	20.87x
Revenue Growth3 Y	15.6x
Revenue Growth5 Y	14.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.82
Assets	EUR 6.4B
Cash	EUR 3.5B
Current Assets	EUR 4.7B
Current Liabilities	EUR 1.3B
Debt	EUR 34.2M
Debt EBITDA	EUR 0.03
Debt Equity	EUR 0.01
Debt FCF	EUR 0.03
Equity	EUR 4.9B
Interest Coverage	622.3
Liabilities	EUR 1.5B
Long Term Assets	EUR 1.7B
Long Term Liabilities	EUR 225.4M
Net Cash	EUR 3.4B
Net Cash By Market Cap	EUR 20.62
Net Cash Growth	68.1%
Net Debt EBITDA	EUR -2.57
Net Debt Equity	EUR -0.71
Net Debt FCF	EUR -2.74
Tangible Book Value	EUR 4.7B
Tangible Book Value Per Share	EUR 23.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.68
Inventory Turnover	28.2
Net Working Capital	EUR -9.7M
Quick ratio	3.4
Working Capital	EUR 3.5B
Working Capital Turnover	EUR 1.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	36.23%
1Y total return	59.38%
200-day SMA	80.28
3Y total return	38.08%
50-day SMA	81.76
50-day SMA vs 200-day SMA	50over200
5Y total return	22.23%
All Time High	144.1
All Time High Change	-42.23%
All Time High Date	2017-03-13
All Time Low	1.57
All Time Low Change	5,203.18%
All Time Low Date	2009-04-24
ATR	1.07
Ch YTD	-0.79
High	83.26
High52	95.56
High52 Date	2026-01-08
High52ch	-12.87%
Low	82.98
Low52	52.56
Low52 Date	2025-05-08
Low52ch	59.38%
Ma50ch	1.84%
Price vs 200-day SMA	3.71%
RSI	54.02
RSI Monthly	59.5
RSI Weekly	53.43
Sharpe ratio	1.43x
Sortino ratio	2.51
Total Return	0.21%
Tr YTD	-0.79
Tr15y	537.03%
Tr1m	2.16%
Tr1w	1.09%
Tr3m	-3.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.3B
Operating Income Growth	593.4
Operating Income Growth Q	49.54
Operating Income Growth3 Y	42.51
Operating Income Growth5 Y	22.82
Operating margin	27.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167,567,809%
Net Borrowing	-3,932,847.8
Shares Insiders	0.46%
Shares Institutions	88.48%
Shares Qo Q	1.01%
Shares Yo Y	-0.21%
Short Ratio	7.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1B
Average Volume	31.5x
Bv Per Share	24.39
CAPEX	EUR -57.2M
Ch10y	36.23
Ch15y	537
Ch1m	2.16
Ch1w	1.09
Ch1y	59.38
Ch20y	2,385.4
Ch3m	-3.77
Ch3y	38.08
Ch5y	22.23
Ch6m	-8.59
Change	-1.49%
Change From Open	0.34
Close	84.52
Days Gap	-1.82
Depreciation Amortization	80,324,048.4
Earnings Date	2026-04-28
EBIT	EUR 1.3B
EBITDA	EUR 1.3B
EPS	EUR 6.12
F Score	7
FCF	EUR 1.3B
FCF EV Yield	9.43x
Financing CF	172,191,140
Fiscal Year End	December
Founded	1,991
Goodwill	112,778,946
Graham Number	58.09529
Graham Upside	-30.22
Income Tax	EUR 296.7M
Investing CF	-166,443,543
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2000-09-01
Last Split Type	Forward
Lynch Fair Value	EUR 151
Lynch Upside	81.93
Ma150	83.65
Ma150ch	-0.47%
Ma20	82.26
Ma20ch	1.22%
Net CF	1,317,916,990
Next Earnings Date	2026-07-28
Open	82.98
P FCF Ratio	13.29
P OCF Ratio	12.72
Position In Range	100
Ppne	633,290,244.2
Price Date	2026-05-08
Price EBITDA	EUR 12.45
Ptbv Ratio	3.59
Relative Volume	13.79x
Revenue	4,649,612,646x
SBC By Revenue	4.71x
Share Based Comp	218,984,577
Tax By Revenue	6.38x
Tax Rate	19.28%
Tr20y	2,385.37%
Tr6m	-8.59%
Volume	0
Z Score	7.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/ICY pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/ICY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/ICY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.5%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/ICY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.0

Neutral momentum band

Price vs 200-day MA

+3.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/ICY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/ICY stock rating?

fra/ICY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/ICY analysis?

The full report lives at /stocks/fra/ICY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/ICY?

The latest report frames fra/ICY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/ICY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.